Litigation screening panels on trial
side note: Another great article from the people at American Medical News. Indiana and 19 other states employ a pretrial screening panel designed to “weed out” non-meritorious malpractice lawsuits. In this article, the author look at how effective these panels have been in lowering physicians’ medical malpractice insurance premiums and the overall cost of malpractice lawsuits. We have re-published the full article so our readers could always have access to it.
by Amy Lynn Sorrel
Many states use pretrial review panels to sift out merit-less cases and encourage early settlement without going to court. Are they working?
Having served on at least 14 pretrial screening panels in the past 20 years, Evansville, Ind., general surgeon Michael B. Hoover, MD, has seen his share of questionable medical liability claims.
In one case, a patient sued over a needle she claimed had broken off in her buttock during an emergency procedure. The screening panel was charged with reviewing the case before it could proceed to court. After examining x-rays, Dr. Hoover and his fellow panel members discovered that the needle was not a hollow surgical needle but a solid needle like those used in sewing.
The case was found to be without merit by the panel and did not see the inside of a courtroom.
“The evaluation is basically a very quick rule-out of any case that might be considered non-meritorious,” Dr. Hoover said. “It not only saves [defendants] time and effort, but it saves the plaintiffs time and effort. What if the case went through to court to find out it was a sewing needle?”
Indiana is one of about 20 states using prelitigation review panels, which proponents tout as a way to temper medical liability costs by weeding out frivolous claims and encouraging early settlement of valid cases. The concept has faced resistance from critics who say it unnecessarily and unfairly drags out the legal process.
A well-designed pretrial screening panel does a very effective job of not only getting claims settled faster, but a higher percentage of the system cost goes to the injured patient, and that’s an important piece of this. What you don’t want to do is create another bureaucratic step that doesn’t do anything but create another hoop you have to jump through and another cost you have to pay,” said Robert J. Walling, a partner with Pinnacle Actuarial Resources Inc.
The actuarial and consulting firm conducted a 2008 study of the issue for the American Medical Association, which views the panels as a promising alternative for states that cannot achieve more effective, traditional liability reforms such as non-economic damage caps. The analysis found that states with screening panels generally had better overall medical liability insurance rates — 20% below the national average — and lower claims costs than states without such laws. States with stronger panel laws also showed a higher percentage of cases that closed without any payout and quicker settlement times.
Efficiency and fairness
While a typical claim takes at least two years to resolve, including an average two-week jury trial, screening panels convene and evaluate cases within a matter of months, usually not more than six. A hearing is conducted over a day or two by a committee of one or more physicians, an attorney and a nonvoting chair, who render a nonbinding opinion. Costs generally are shared by the parties or covered by the state. Panel members may be appointed by a court or selected by both sides.
The process offers plaintiffs access to an expert review at little or no expense, Dr. Hoover said. And regardless of the opinion, it does not interfere with parties’ ability to go to trial, where either side can use a panel opinion as evidence.
“The panel does not have the right to be the ultimate decision-maker. It just provides the expertise” to help parties resolve claims more efficiently, Dr. Hoover said.
Supporters have heralded a nearly 25-year-old, mandatory screening process in Maine, where 84% of claims end without any payment and average settlement times are roughly half those found in some other states without panel laws, according to the AMA report. Only unanimous findings are admissible in court, and parties can agree to make the early findings binding.
“If the process doesn’t have the power or authority or weight to force a change in the legal process, then it has no teeth,” Walling said.
Maine Medical Assn. Executive Vice President Gordon H. Smith said the system has helped resolve a majority of cases before trial and contributed to a relatively stable liability climate. Insurance rates are 20% to 30% lower than those in neighboring New Hampshire, which, until recently, had no panel law.
“Given that Maine doesn’t have a cap on [non-economic] awards, the panels, along with a reasonable statute of limitations, are the things that have made the most difference,” Smith said.
As further evidence of Maine’s success, average claims expenses were 66% higher in New Hampshire between 1996 and 2006, noted Michael L. McCall, senior vice president of insurance operations for Medical Mutual Insurance Co. of Maine, which operates in both states. During the same period, only 2.5% of Maine cases went to trial, compared with 7% in New Hampshire.
“You can appreciate the cost differential if you’re working up every case in preparation for the one bite of the apple before a jury trial, instead of preparing for a one-day hearing,” McCall said.
New Hampshire doctors are hoping to close those gaps. In 2005, the state became the latest to enact a panel law modeled after its neighbor’s. The statute requires a study of the panels’ effects with findings due by December 2010.
While still early to gauge the panels’ impact on the state’s liability climate, New Hampshire Medical Society Immediate Past President Oglesby H. Young III, MD, said they are working. He pointed to recent statistics showing that, of the 48 cases that have gone before a panel, only four went on to a jury trial.
But not everyone is sold that review panels are a proven way to reduce costs and hassles.
New Hampshire trial lawyers backed an attempt in 2008 to repeal the state panel law, pointing to long delays of 15 months before cases reached a panel.
“That arbitrary barrier is not only delaying access to justice, but in some cases foreclosing it,” said Ellen J. Shemitz, executive director of the New Hampshire Assn. for Justice, the state trial bar.
Plaintiffs are essentially forced to try their cases twice, making it difficult for attorneys to afford taking smaller cases, she said. Now, however, the state has a mediation process overseen by the courts — not in place at the time the panel law passed — to help resolve claims out of court.
Shemitz also said the rules preventing plaintiffs — but not defendants — from using split panel findings in court are unfair.
But Dr. Young said the legal standards for panels are the same as they are in court and require plaintiffs to win on both negligence and causation. He said the time lags resulted from a wave of constitutional challenges from trial lawyers that kept the panel law from taking effect until 2007.
Through the years, roughly 30 states have repealed their panel laws either legislatively or judicially.
Nevada was one of them. But problems arose largely because players did not abide by the rules, not because of the system itself, said Rudy R. Manthei, DO, a Henderson, Nev., ophthalmologist who helped push for other tort reform that eventually replaced the panel system.
“It started breaking down in terms of functionality,” he said. Doctors and lawyers who signed up to serve on panels “wouldn’t show up, and you’d end up canceling and creating huge delays. So it really fell out of what it was meant to do.”
Virginia’s decades-old system, while still on the books, is no longer used, largely because it is optional, said Gerald C. Canaan III, a medical liability defense lawyer and director with Hancock, Daniel, Johnson & Nagle PC in Glen Allen, Va.
“People quickly realized if both sides didn’t participate, it nullified the weight of the panel opinion at trial,” he said. “It doesn’t do me any good to get an opinion that doesn’t carry any weight in court … and it just became expensive for both sides.”
Valparaiso, Ind., plaintiff lawyer Steven L. Langer said panels become moot when insurance companies refuse to settle a claim, despite an adverse panel finding. “I agree that no doctor should be sued frivolously. But no doctor should be able to create a frivolous defense,” said Langer, who is preparing for trials in three cases where patients won panel decisions.